Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by toinv261on Mar 14, 2014 2:54pm
143 Views
Post# 22325154

Financing Phase 3 thoughts

Financing Phase 3 thoughtsMusings.

If Dr. Wong indicated that Mr. Kennith Dart is willing to fund the phase 3 trial it seems to imply he would do this after it passes phase 2c i.e. he'd bet his money at the next stage but not at phase 2c. He has already invested significant $ into RVX and is not turning away (it seems).

Eastern Capital owns 20% so they must have about $13M to $15M invested.

It strikes me that these are both very strong votes of confidence in rvx-208.

I wonder if Mr. Dart would fund phase 2c? Perhaps we'll see.

I'm getting more re-assured
Toinv
Bullboard Posts